NAD Injections for Weight Loss: What Is Actually Known

Weight-loss claims for NAD+ are not supported by controlled human trials, yet NAD injections for weight loss are a fixture of med-spa menus and social media. Meanwhile, on 24 August 2026, FDA sent warning letters to five online peptide vendors over unapproved weight-loss drugs including semaglutide, tirzepatide and retatrutide. The weight-loss end of this market is where marketing runs furthest ahead of the evidence and where regulators are paying the closest attention.

This page sets out what is known, what is not, and why we do not present any NAD+ product as a weight-loss tool. Injectable NAD+ is not FDA-approved for weight loss or anything else.

Why NAD+ Gets Linked to Weight Loss

NAD+ gets linked to weight loss because it is central to energy metabolism, and "metabolism" is easily stretched into "fat burning" in marketing copy. Many studies also report that NAD+ levels decline with age, which sellers pair with the common experience of weight gain later in life.

The timing helps the marketing too. Weight-loss injections such as semaglutide and tirzepatide have drawn huge public attention, and NAD injections for weight loss ride that interest even though NAD+ has no controlled human weight-loss trials behind it.

Both observations are real. Neither shows that injecting NAD+ causes a person to lose weight. Biochemical involvement in metabolism is true of many molecules that have no effect on body weight when given as a supplement or injection.

What Controlled Human Data Shows

No controlled human trial in the facts we rely on supports NAD+ injections for weight loss. Human evidence for injectable NAD+ benefits in general, including energy, ageing and weight, is limited, and the stronger data concern cell and animal models.

When you read a clinic page that claims patients "lose more weight with NAD+", check three things:

1. Is there a control group, or is it a before-and-after description?
2. Were patients also dieting, exercising or taking a GLP-1 drug at the same time?
3. Was the result published, or is it a testimonial?

Most claims fail at the first step. We cover the wider evidence picture on NAD injection benefits.

Related Metabolic Research Compounds

Some research compounds that sit near NAD+ in the metabolism literature have animal data, but none has human weight-loss evidence. These are research materials sold for lab use only.

5-Amino-1MQ is a small molecule rather than a peptide, and it links to the NAD+ story because NNMT is involved in nicotinamide metabolism. MOTS-c was among the six peptides an FDA advisory committee recommended for the 503A bulks list in July 2026, by an 8-6 vote with one abstention. That vote is non-binding and not final. Neither compound is FDA-approved.

Weight-Loss Marketing and FDA Enforcement

FDA's August 2026 warning letters show how the agency treats weight-loss marketing for unapproved products: it looks at the whole website, and disease claims, dosing guidance and reconstitution calculators count as evidence of human use. "Research use only" labels did not protect the five vendors.

NAD+ was not among the products named in those letters. Still, a site that sold NAD injections for weight loss with dosing advice would be making the same kind of claims that drew enforcement. That is why we publish no use guidance and make no weight claims. Our page on NAD injection prescriptions explains the legal route for people.

A Realistic Way to Think About It

If weight is your goal, NAD+ is not a proven tool for it, and a doctor is the right person to discuss options that do have trial evidence. A telehealth prescriber such as Arc-1, whose NAD+ Injections are listed at $299.99 with a physician consultation, can assess whether NAD+ has any place in your plan, and may well say it does not.

Be careful with programs that bundle NAD+ with a weight-loss drug and then credit the NAD+ for the result. When two things change at once, nobody can say which one did the work, and only a controlled trial could separate them.

We would rather tell you that plainly than sell a story. For a broader look at the compounds people group with NAD+, see the NAD+ longevity compounds page.